Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity.
Activation of human platelets by complement proteins C5b-9 is accompanied by the release of small plasma membrane vesicles (microparticles) that are highly enriched in binding sites for coagulation factor Va and exhibit prothrombinase activity. We have now examined whether assembly of the prothrombinase enzyme complex (factors VaXa) is directly linked to the process of microparticle formation. Gel-filtered platelets were incubated without stirring with various agonists at 37 degrees C, and the functional expression of cell surface receptors on platelets and on shed microparticles was analyzed using specific monoclonal antibodies and fluorescence-gated flow cytometry. In addition to the C5b-9 proteins, thrombin, collagen, and the calcium ionophore A23187 were each found to induce formation of platelet microparticles that incorporated plasma membrane glycoproteins GP Ib, IIb, and IIIa. These microparticles were enriched in binding sites for factor Va, and their formation paralleled the expression of catalytic surface for the prothrombinase enzyme complex. Little or no microparticle release or prothrombinase activity were observed when platelets were stimulated with epinephrine and ADP, despite exposure of platelet fibrinogen receptors by these agonists. When platelets were exposed to thrombin plus collagen, the shed microparticles contained activated GP IIb-IIIa complexes that bound fibrinogen. By contrast, GP IIb-IIIa incorporated into C5b-9 induced microparticles did not express fibrinogen receptor function. Platelets from a patient with an isolated defect in inducible procoagulant activity (Scott syndrome) were found to be markedly impaired in their capacity to generate microparticles in response to all platelet activators, and this was accompanied by a comparable decrease in the number and function of inducible factor Va receptors. Taken together, these data indicate that the exposure of the platelet factor Va receptor is directly coupled to plasma membrane vesiculation and that this event can be dissociated from other activation-dependent platelet responses. Since a catalytic membrane surface is required for optimal thrombin generation, platelet microparticle formation may play a role in the normal hemostatic response to vascular injury.
Sims
P J
PJ
Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City 73104.
Wiedmer
T
T
Esmon
C T
CT
Weiss
H J
HJ
Shattil
S J
SJ
D000911:Antibodies, Monoclonal; D001779:Blood Coagulation Factors / Q000502:physiology; D001792:Blood Platelets / Q000201:enzymology* / Q000648:ultrastructure; D002462:Cell Membrane / Q000502:physiology*; D003094:Collagen / Q000494:pharmacology; D015938:Complement Membrane Attack Complex / Q000494:pharmacology; D005434:Flow Cytometry; D006801:Humans; D015539:Platelet Activation / Q000502:physiology*; D010980:Platelet Membrane Glycoproteins / Q000378:metabolism; D013577:Syndrome; D013917:Thrombin / Q000494:pharmacology; D013925:Thromboplastin / Q000378:metabolism*
D000911:Antibodies, Monoclonal; D001779:Blood Coagulation Factors; D015938:Complement Membrane Attack Complex; D010980:Platelet Membrane Glycoproteins; C049426:platelet procoagulant factor; D003094:Collagen; D013925:Thromboplastin; D013917:Thrombin